SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-013805
Filing Date
2022-05-27
Accepted
2022-05-27 17:16:29
Documents
24
Period of Report
2022-04-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20220527_8k.htm   iXBRL 8-K 44788
2 EXHIBIT 1.1 ex_381474.htm EX-1.1 5334
3 EXHIBIT 99.1 ex_381429.htm EX-99.1 24867
4 EXHIBIT 99.2 ex_381430.htm EX-99.2 17035
9 a01.jpg GRAPHIC 901067
10 a02.jpg GRAPHIC 904288
11 a03.jpg GRAPHIC 761288
12 a04.jpg GRAPHIC 609005
13 a05.jpg GRAPHIC 609773
14 a06.jpg GRAPHIC 782546
15 a07.jpg GRAPHIC 654765
16 a08.jpg GRAPHIC 589493
  Complete submission text file 0001437749-22-013805.txt   8214344

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA stab-20220418.xsd EX-101.SCH 3601
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stab-20220418_def.xml EX-101.DEF 11532
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE stab-20220418_lab.xml EX-101.LAB 15414
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stab-20220418_pre.xml EX-101.PRE 11688
18 EXTRACTED XBRL INSTANCE DOCUMENT cbli20220527_8k_htm.xml XML 2571
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 22978958
SIC: 2834 Pharmaceutical Preparations